Shrinath Kshirsagar

Linezolid-induced Sideroblastic Anaemia: A Reversible but Overlooked Adverse Effect

Miet D. Shah, Shrinath Kshirsagar, Taher Varawala, Samiksha Sankhe, Manaswi Jadhav & Niharika Gill · Journal of Pharmaceutical Research International · 2024

With the ever-evolving guidelines and changing drug regimens for tuberculosis (TB), it is paramount for treating physicians to understand the efficacy and safety profiles of the drugs being used. Linezolid is included in the treatment of multidrug-resistant (MDR) and extensively...

Open access Research Article 10.9734/jpri/2024/v36i117621

Observational Study on Dual Marker of T Cell Activation for Early Diagnosis of Hemophagocytic lymphohistiocytosis (HLH) on Peripheral Blood

Abhay A. Bhave, Sarang Waghmare, Nitin Chavan, Kashvi Mehta, Fatema Rangwalla & Shrinath Kshirsagar · Asian Hematology Research Journal · 2023

Introduction: Hemophagocytic lymphohistiocytosis (HLH) is a fatal disorder, characterized by a cytokine storm due to cytotoxic T cell activation, the causes of which are various. Its detection is first on clinical awareness and proved by several tests. However, there is not one s...

Open access Research Article